The investment equips Rani to step up manufacturing of its robotic, oral biologic delivery pill in anticipation of moving the devices into the clinic.

Zenflow will use the series A funds to trial a minimally invasive device designed to treat urinary symptoms in patients with enlarged prostates.

Smith & Nephew, a London-based medical device maker, has launched its new single-use negative pressure wound system in the European market.

The collaboration gives Medopad access to the nearly 1 billion users of Tencent’s WeChat messaging service.

The trial is assessing the use of technology for harvesting circulating tumor cells in combination with Abbott’s test of HER-2 status.

Cam Med is working on a patch pump as an alternative to traditional insulin pumps in "artificial pancreas" systems.

InVivo Therapeutics, which specializes in spinal cord injuries, names Richard Toselli, M.D., as its president and chief executive.

Intarcia halted a pair of phase 3 trials, but they are not required for the FDA to approve its drug-device diabetes treatment.